How do I install the Endo Srt Over Conventional Rt Unless Constraints skill?

Run npx skillmds@latest add dromlakhani/endo-srt-over-conventional-rt-unless-constraints in your terminal (requires Node.js), paste this page's agent-chat prompt into Claude, Cursor, or any MCP-connected agent, or download the SKILL.md file and copy it into your agent's skills directory.

Is Endo Srt Over Conventional Rt Unless Constraints safe to use?

This skill has not completed SkillMD's automated safety review yet. Independent scanners report: SkillSpector: PASS, Skill Scanner: PASS. Capability flags: docs only. SkillMD never runs a skill's scripts for you; review the SKILL.md before installing.

Which AI agents work with Endo Srt Over Conventional Rt Unless Constraints?

This skill is tagged as working with Claude Code, Claude.ai, OpenAI Codex. SKILL.md is an open format, so most agents that read a skills directory can load it too.

Is Endo Srt Over Conventional Rt Unless Constraints free to use?

Yes. Installing skills from SkillMD is free, and the skill stays under its author's original license.

Who published Endo Srt Over Conventional Rt Unless Constraints?

dromlakhani (@dromlakhani) published this skill. Their other Agent Skills are listed on their SkillMD profile.

Endo Srt Over Conventional Rt Unless Constraints by dromlakhani

Name: Endo Srt Over Conventional Rt Unless Constraints
Rating: 4.2 (5 reviews)
Author: dromlakhani

Endo Srt Over Conventional Rt Unless Constraints

Recommends stereotactic radiotherapy (SRT) over conventional radiotherapy for acromegaly when adjuvant radiation is indicated after surgery or failed medical therapy, unless SRT is unavailable, there is significant residual tumor burden, or the tumor’s proximity to the optic chiasm predicts an exposure exceeding 8 Gy. Trigger phrases include ‘residual tumor mass’, ‘SRT not available’, ‘optic chiasm dose >8 Gy’.

dromlakhani Updated Sep 8, 2026 10 repo stars

File contents

Prefer stereotactic radiotherapy over conventional RT unless specific constraints

STEP 1 — Gather Information

Confirm persistent disease after surgery and/or medical therapy (or medical therapy unavailable/unsuccessful/not tolerated); obtain postoperative MRI/CT to measure residual tumor volume and distance from optic chiasm; verify local availability of SRT equipment.

STEP 2 — Rule In / Rule Out

Is radiotherapy indicated for adjuvant treatment? If yes (persistent disease after surgery/medical therapy or medical therapy not an option), proceed to Step 3; if no, consider continued medical therapy or observation.

STEP 3 — Classify or Stratify

Assess three constraints: (1) SRT unavailable? (2) Significant residual tumor burden (e.g., volume >10 cm³ or invasive growth)? (3) Predicted optic chiasm dose >8 Gy (based on tumor‑chiasm distance and prescribed dose). If any constraint is present, classify as “conventional RT preferred”; otherwise classify as “SRT preferred”.

STEP 4 — Decide

If classified as “SRT preferred”, schedule stereotactic radiotherapy (single‑fraction or hypofractionated) per institutional protocol; if classified as “conventional RT preferred”, plan conventional fractionated radiotherapy (e.g., 45–50 Gy in 25 fractions) or consider alternative management.

Clinical Guardrails / Mimics / Pitfalls

Do not use SRT when predicted optic chiasm dose exceeds 8 Gy due to risk of radiation‑induced visual loss; avoid SRT in cases of large invasive tumor burden where conventional wider fields may be needed; ensure SRT planning includes dose‑volume constraints for optic apparatus; verify that residual tumor burden assessment uses contrast‑enhanced MRI; never omit dose calculation for optic chiasm when tumor is within 5 mm of the chiasm.

Concrete Clinical Example

A 48‑year‑old woman with acromegaly has persistent IGF‑1 elevation after transsphenoidal surgery and failed somatostatin ligand therapy. MRI shows a 0.8 cm³ residual tumor 4 mm from the optic chiasm; SRT is available. Dose‑prediction estimates 6 Gy to the chiasm (<8 Gy). No significant residual burden. Decision: proceed with SRT (single‑fraction 19 Gy).

Source: Acromegaly: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2014, DOI:10.1210/jc.2014-2700

TODO: consider adding scripts/calc.py for the endo-srt-over-conventional-rt-unless-constraints calculator

---name: endo-srt-over-conventional-rt-unless-constraintsdescription: Recommends stereotactic radiotherapy (SRT) over conventional radiotherapy for acromegaly when adjuvant radiation is indicated after surgery or failed medical therapy, unless SRT is unavailable, there is significant residual tumor burden, or the tumor’s proximity to the optic chiasm predicts an exposure exceeding 8 Gy. Trigger phrases include ‘residual tumor mass’, ‘SRT not available’, ‘optic chiasm dose >8 Gy’.---# Prefer stereotactic radiotherapy over conventional RT unless specific constraints## STEP 1 — Gather InformationConfirm persistent disease after surgery and/or medical therapy (or medical therapy unavailable/unsuccessful/not tolerated); obtain postoperative MRI/CT to measure residual tumor volume and distance from optic chiasm; verify local availability of SRT equipment.## STEP 2 — Rule In / Rule OutIs radiotherapy indicated for adjuvant treatment? If yes (persistent disease after surgery/medical therapy or medical therapy not an option), proceed to Step 3; if no, consider continued medical therapy or observation.## STEP 3 — Classify or StratifyAssess three constraints: (1) SRT unavailable? (2) Significant residual tumor burden (e.g., volume >10 cm³ or invasive growth)? (3) Predicted optic chiasm dose >8 Gy (based on tumor‑chiasm distance and prescribed dose). If any constraint is present, classify as “conventional RT preferred”; otherwise classify as “SRT preferred”.## STEP 4 — DecideIf classified as “SRT preferred”, schedule stereotactic radiotherapy (single‑fraction or hypofractionated) per institutional protocol; if classified as “conventional RT preferred”, plan conventional fractionated radiotherapy (e.g., 45–50 Gy in 25 fractions) or consider alternative management.## Clinical Guardrails / Mimics / PitfallsDo not use SRT when predicted optic chiasm dose exceeds 8 Gy due to risk of radiation‑induced visual loss; avoid SRT in cases of large invasive tumor burden where conventional wider fields may be needed; ensure SRT planning includes dose‑volume constraints for optic apparatus; verify that residual tumor burden assessment uses contrast‑enhanced MRI; never omit dose calculation for optic chiasm when tumor is within 5 mm of the chiasm.## Concrete Clinical ExampleA 48‑year‑old woman with acromegaly has persistent IGF‑1 elevation after transsphenoidal surgery and failed somatostatin ligand therapy. MRI shows a 0.8 cm³ residual tumor 4 mm from the optic chiasm; SRT is available. Dose‑prediction estimates 6 Gy to the chiasm (<8 Gy). No significant residual burden. Decision: proceed with SRT (single‑fraction 19 Gy).**Source:** Acromegaly: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2014, DOI:10.1210/jc.2014-2700> **TODO:** consider adding scripts/calc.py for the endo-srt-over-conventional-rt-unless-constraints calculator

Frequently asked questions